During the past decade, Kangwon National University Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kangwon National University Hospital" #1 collaborator was "Janssen Korea, Ltd., Korea" with 1 trials as a collaborator and "Korea Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Kangwon National University Hospital" are "First Episode Psychosis" (2 trials), "Type 2 Diabetes" (2 trials) and "Diabetes" (1 trials). Many other conditions were trialed in "Kangwon National University Hospital" in a lesser frequency.

Most popular intervention types in "Kangwon National University Hospital" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Insulin Degludec" (2 trials), "Insulin Efsitora Alfa" (2 trials), "Aripiprazole" (1 trials) and "paliperidone ER" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kangwon National University Hospital" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Kangwon National University Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kangwon National University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kangwon National University Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".